Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

REMS Prescriber and Pharmacist Understanding of the Risk of Urinary Retention With POTIGA™

NCT01938560 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT01938560
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01938560 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
REMS Prescriber and Pharmacist Understanding of the Risk of Urinary Retention With POTIGA™
Lead sponsor
GlaxoSmithKline
Phase
Observational
Overall status
Completed
Start date
February 28, 2013
Completion date
May 31, 2013
Enrollment
1 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

epilepsy